Ovid Therapeutics Inc. (FRA:1OT)

Ovid Therapeutics Revenue

Ovid Therapeutics had revenue of $132.00K USD in the quarter ending September 30, 2025, a decrease of -23.70%. This brings the company's revenue in the last twelve months to $6.61M, up 945.89% year-over-year. In the year 2024, Ovid Therapeutics had annual revenue of $566.00K with 44.39% growth.

• Revenue (ttm): $6.61M
• Revenue Growth: +945.89%
• P/S Ratio: 19.57
• Revenue / Employee: $287.39K
• Employees: 23
• Market Cap: 110.26M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	566.00K	174.00K	44.39%
Dec 31, 2023	392.00K	-1.11M	-73.91%
Dec 31, 2022	1.50M	-206.88M	-99.28%
Dec 31, 2021	208.38M	195.77M	1,551.57%
Dec 31, 2020	12.62M	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-